Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution - NEC
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:ALGN
- CUSIP: 01625510
- Web: www.aligntech.com
Capitalization:- Market Cap: $12.76224 billion
- Outstanding Shares: 80,331,000
Average Prices:- 50 Day Moving Avg: $151.04
- 200 Day Moving Avg: $122.88
- 52 Week Range: $82.60 - $161.81
P/E:- Trailing P/E Ratio: 60.15
- Foreward P/E Ratio: 40.60
- P/E Growth: 2.08
Sales & Book Value:- Annual Revenue: $1.15 billion
- Price / Sales: 11.26
- Book Value: $13.01 per share
- Price / Book: 12.39
Profitability:- EBIDTA: $284.34 million
- Net Margins: 18.98%
- Return on Equity: 22.95%
- Return on Assets: 16.47%
Debt:- Current Ratio: 2.51%
- Quick Ratio: 2.42%
Misc:- Average Volume: 1.28 million shs.
- Beta: 1.53
- Short Ratio: 1.47
Frequently Asked Questions for Align Technology (NASDAQ:ALGN)
What is Align Technology's stock symbol?
Align Technology trades on the NASDAQ under the ticker symbol "ALGN."
How were Align Technology's earnings last quarter?
Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings data on Thursday, April, 27th. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.18. The firm earned $310.34 million during the quarter, compared to analysts' expectations of $297.46 million. Align Technology had a return on equity of 22.95% and a net margin of 18.98%. The company's revenue for the quarter was up 30.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.50 EPS. View Align Technology's Earnings History.
When will Align Technology make its next earnings announcement?
Where is Align Technology's stock going? Where will Align Technology's stock price be in 2017?
7 analysts have issued 1 year price objectives for Align Technology's shares. Their predictions range from $150.00 to $200.00. On average, they anticipate Align Technology's share price to reach $176.71 in the next twelve months. View Analyst Ratings for Align Technology.
What are analysts saying about Align Technology stock?
Here are some recent quotes from research analysts about Align Technology stock:
- 1. Leerink Swann analysts commented, "healthy" (6/26/2017)
- 2. According to Zacks Investment Research, "Ahead of its first quarter 2017 earnings, Align Technology is trading above the Zacks categorized Medical/Dental-Supplies industry for the last three months. The company’s consistently strong volumes led to top-line growth in the last reported fourth quarter 2016 earnings. Additionally, the company has a strong cash balance that enables it to adopt attractive share repurchase programs and in turn provide solid returns to investors. Going forward, management anticipates consistent growth in the Asia-Pacific region. On the flip side, currency movement continued to hurt its fourth-quarter results. The company also witnessed dull international invasilign revenue due to shipment related problem. A competitive landscape and macroeconomic headwinds continue to impact dental procedures." (4/11/2017)
Who are some of Align Technology's key competitors?
Some companies that are related to Align Technology include C.R. Bard (BCR), DENTSPLY SIRONA (XRAY), Steris Plc (STE), Bio-Rad Laboratories (BIO), West Pharmaceutical Services (WST), DexCom (DXCM), Hill-Rom Holdings (HRC), VWR Corp (VWR), Integra LifeSciences Holdings Corporation (IART), NuVasive (NUVA), ICU Medical (ICUI), LivaNova PLC (LIVN), Neogen Corporation (NEOG), Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Inogen (INGN), Halyard Health (HYH) and MiMedx Group (MDXG).
Who are Align Technology's key executives?
Align Technology's management team includes the folowing people:
- Charles Raymond Larkin Jr., Independent Chairman of the Board
- Joseph M. Hogan, President, Chief Executive Officer, Director
- John F. Morici, Chief Financial Officer
- Emory M. Wright, Vice President - Operations
- Roger E. George, Vice President - Corporate and Legal Affairs and General Counsel
- Simon Beard, Vice President, Managing Director - EMEA
- Jennifer Olson, Vice President and Managing Director - Doctor Directed Consumer Channel
- Christopher C. Puco, Vice President, Managing Director - North America
- Julie Tay, Vice President, Managing Director - Asia Pacific
- Stuart Hockridge, Vice President - Global Human Resources
Who owns Align Technology stock?
Align Technology's stock is owned by many different of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (0.50%), Conestoga Capital Advisors LLC (0.26%), Bank of Montreal Can (0.25%), GW&K Investment Management LLC (0.25%), US Bancorp DE (0.23%) and Vontobel Asset Management Inc. (0.16%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David C Nagel, David L White, Emory Wright, George J Morrow, Greg J Santora, Jennifer Erfurth, Jennifer Olson, Joseph Lacob, Julie Tay, Raphael Pascaud, Roger E George, Sreelakshmi Kolli, Thomas M Prescott, Timothy A Mack, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.
Who sold Align Technology stock? Who is selling Align Technology stock?
Align Technology's stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Conestoga Capital Advisors LLC, Vontobel Asset Management Inc., Oregon Public Employees Retirement Fund, Louisiana State Employees Retirement System, US Bancorp DE, State Treasurer State of Michigan and Sit Investment Associates Inc.. Company insiders that have sold Align Technology stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Jennifer Olson, Joseph Lacob, Julie Tay, Sreelakshmi Kolli, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Insider Buying and Selling for Align Technology.
Who bought Align Technology stock? Who is buying Align Technology stock?
Align Technology's stock was bought by a variety of institutional investors in the last quarter, including Chevy Chase Trust Holdings Inc., Gateway Investment Advisers LLC, Bank of Montreal Can, GW&K Investment Management LLC, Exxonmobil Investment Management Inc. TX, Mn Services Vermogensbeheer B.V., Bedrijfstakpensioenfonds Voor DE Media PNO and APG Asset Management N.V.. View Insider Buying and Selling for Align Technology.
How do I buy Align Technology stock?
Shares of Align Technology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Align Technology's stock price today?
One share of Align Technology stock can currently be purchased for approximately $161.19.
MarketBeat Community Rating for Align Technology (NASDAQ ALGN)MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Align Technology (NASDAQ:ALGN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 7 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $176.71 (9.63% upside) |
Analysts' Ratings History for Align Technology (NASDAQ:ALGN)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/17/2017 | Morgan Stanley | Reiterated Rating | Overweight | $175.00 -> $182.00 | Low |  |
| 7/13/2017 | Credit Suisse Group | Reiterated Rating | Outperform | $140.00 -> $170.00 | Low | |
| 6/26/2017 | Leerink Swann | Boost Price Target | Outperform | $149.00 -> $194.00 | Low | |
| 6/23/2017 | Stifel Nicolaus | Reiterated Rating | Market Perform -> Buy | $145.00 -> $200.00 | High | |
| 6/21/2017 | Northcoast Research | Reiterated Rating | Buy | $164.00 -> $186.00 | Low | |
| 6/1/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $150.00 | Low | |
| 4/28/2017 | Robert W. Baird | Upgrade | Neutral -> Outperform | $105.00 -> $155.00 | High | |
| 5/17/2016 | Piper Jaffray Companies | Reiterated Rating | Overweight | $74.00 -> $82.00 | N/A | |
| 3/24/2016 | Canaccord Genuity | Reiterated Rating | Buy | $72.00 -> $80.00 | N/A | |
| 3/23/2016 | Roth Capital | Boost Price Target | Buy | $72.00 -> $80.00 | N/A | |
| 1/29/2016 | William Blair | Reiterated Rating | Buy | | N/A | |
| 1/29/2016 | Goldman Sachs Group, Inc. (The) | Boost Price Target | Buy | $67.00 -> $72.00 | N/A | |
(Data available from 7/25/2015 forward)
Earnings History for Align Technology (NASDAQ:ALGN)Earnings History by Quarter for Align Technology (NASDAQ ALGN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/27/2017 | | $0.73 | | | | | N/A | |
| 4/27/2017 | Q1 2017 | $0.67 | $0.85 | $297.46 million | $310.34 million | View | N/A | |
| 1/31/2017 | Q416 | $0.66 | $0.59 | $292.75 million | $293.20 million | View | N/A | |
| 11/7/2016 | Q3 | $0.52 | $0.63 | $271.61 million | $278.60 million | View | Listen | |
| 7/28/2016 | Q2 | $0.48 | $0.62 | $259.29 million | $269.40 million | View | Listen | |
| 4/28/2016 | Q116 | $0.40 | $0.50 | $236.22 million | $238.70 million | View | Listen | |
| 1/28/2016 | Q415 | $0.52 | $0.60 | $226.68 million | $230.30 million | View | Listen | |
| 10/22/2015 | Q315 | $0.34 | $0.34 | $205.10 million | $207.64 million | View | Listen | |
| 7/23/2015 | Q215 | $0.37 | $0.39 | $209.14 million | $209.50 million | View | Listen | |
| 4/23/2015 | Q115 | $0.32 | $0.38 | $190.89 million | $198.10 million | View | N/A | |
| 1/29/2015 | Q414 | $0.49 | $0.48 | $198.10 million | $198.60 million | View | N/A | |
| 10/23/2014 | Q314 | $0.43 | $0.47 | $188.70 million | $189.90 million | View | Listen | |
| 7/24/2014 | Q214 | $0.39 | $0.43 | $185.80 million | $192.53 million | View | N/A | |
| 4/23/2014 | Q114 | $0.35 | $0.39 | $177.57 million | $180.60 million | View | N/A | |
| 1/31/2014 | Q413 | $0.43 | $0.51 | $172.24 million | $178.30 million | View | N/A | |
| 10/17/2013 | Q313 | $0.30 | $0.42 | $158.64 million | $164.50 million | View | N/A | |
| 7/18/2013 | Q2 2013 | $0.28 | $0.36 | $156.13 million | $163.80 million | View | N/A | |
| 4/18/2013 | Q1 2013 | $0.23 | $0.26 | $149.40 million | $153.60 million | View | N/A | |
| 1/30/2013 | Q4 2012 | $0.22 | $0.27 | $134.75 million | $142.80 million | View | N/A | |
| 10/17/2012 | | $0.29 | $0.28 | | | View | N/A | |
| 7/19/2012 | | $0.28 | $0.34 | | | View | N/A | |
| 4/23/2012 | | $0.21 | $0.27 | | | View | N/A | |
| 1/30/2012 | | $0.21 | $0.28 | | | View | N/A | |
| 10/27/2011 | | $0.19 | $0.27 | | | View | N/A | |
| 8/1/2011 | | $0.20 | $0.20 | | | View | N/A | |
| 4/20/2011 | | $0.17 | $0.21 | | | View | N/A | |
| 1/26/2011 | | $0.17 | $0.14 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Align Technology (NASDAQ:ALGN)2017 EPS Consensus Estimate: $3.05
2018 EPS Consensus Estimate: $3.92
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | $0.65 | $0.70 | $0.67 |
| Q2 2017 | 5 | $0.62 | $0.76 | $0.71 |
| Q3 2017 | 5 | $0.73 | $0.82 | $0.78 |
| Q4 2017 | 5 | $0.85 | $0.93 | $0.89 |
| Q1 2018 | 4 | $0.80 | $0.89 | $0.84 |
| Q2 2018 | 4 | $0.87 | $1.07 | $0.97 |
| Q3 2018 | 4 | $0.89 | $1.12 | $1.01 |
| Q4 2018 | 4 | $0.97 | $1.22 | $1.10 |
(Data provided by Zacks Investment Research)
Dividend History for Align Technology (NASDAQ:ALGN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Align Technology (NASDAQ:ALGN)Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 87.93%
Insider Trades by Quarter for Align Technology (NASDAQ:ALGN)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/31/2017 | Joseph Lacob | Director | Sell | 50,000 | $144.98 | $7,249,000.00 | |
| 5/30/2017 | Joseph Lacob | Director | Sell | 3,874 | $143.96 | $557,701.04 | |
| 5/30/2017 | Sreelakshmi Kolli | VP | Sell | 1,000 | $144.00 | $144,000.00 | |
| 2/28/2017 | Joseph Lacob | Director | Sell | 50,000 | $102.67 | $5,133,500.00 | |
| 2/24/2017 | Christopher C Puco | VP | Sell | 24,353 | $101.88 | $2,481,083.64 | |
| 2/22/2017 | Thomas M Prescott | Director | Sell | 66,528 | $101.12 | $6,727,311.36 | |
| 2/15/2017 | Andrea Lynn Saia | Director | Sell | 4,000 | $99.68 | $398,720.00 | |
| 2/3/2017 | C Raymond Larkin Jr | Director | Sell | 15,000 | $94.71 | $1,420,650.00 | |
| 11/29/2016 | Jennifer Olson | VP | Sell | 3,662 | $95.44 | $349,501.28 | |
| 11/29/2016 | Warren S Thaler | Director | Sell | 8,500 | $95.57 | $812,345.00 | |
| 11/18/2016 | David L White | CFO | Sell | 11,152 | $95.53 | $1,065,350.56 | |
| 11/14/2016 | Thomas M Prescott | Director | Sell | 33,125 | $90.60 | $3,001,125.00 | |
| 8/29/2016 | Jennifer Olson | VP | Sell | 799 | $93.30 | $74,546.70 | |
| 8/15/2016 | Zelko Relic | VP | Sell | 13,577 | $95.91 | $1,302,170.07 | |
| 8/9/2016 | Julie Tay | VP | Sell | 3,000 | $92.60 | $277,800.00 | |
| 5/23/2016 | George J Morrow | Director | Sell | 50,000 | $77.72 | $3,886,000.00 | |
| 5/16/2016 | Raphael Pascaud | VP | Sell | 3,000 | $77.00 | $231,000.00 | |
| 5/10/2016 | Julie Tay | VP | Sell | 1,250 | $77.00 | $96,250.00 | |
| 5/5/2016 | C Raymond Larkin Jr | Director | Sell | 15,000 | $74.36 | $1,115,400.00 | |
| 5/5/2016 | Roger E George | VP | Sell | 27,311 | $75.00 | $2,048,325.00 | |
| 5/3/2016 | Julie Tay | VP | Sell | 1,754 | $75.00 | $131,550.00 | |
| 5/3/2016 | Thomas M Prescott | Director | Sell | 64,773 | $74.54 | $4,828,179.42 | |
| 2/25/2016 | Christopher C Puco | VP | Sell | 11,413 | $63.51 | $724,839.63 | |
| 2/23/2016 | Timothy A. Mack | VP | Sell | 28,384 | $63.25 | $1,795,288.00 | |
| 2/22/2016 | Christopher C. Puco | VP | Sell | 6,278 | $64.01 | $401,854.78 | |
| 2/4/2016 | Greg J Santora | Director | Sell | 9,000 | $67.28 | $605,520.00 | |
| 1/5/2016 | David C Nagel | Director | Sell | 1,100 | $64.64 | $71,104.00 | |
| 12/14/2015 | David C Nagel | Director | Sell | 1,100 | $65.20 | $71,720.00 | |
| 11/2/2015 | Julie Tay | VP | Sell | 1,500 | $66.67 | $100,005.00 | |
| 10/30/2015 | Emory Wright | VP | Sell | 25,272 | $65.04 | $1,643,690.88 | |
| 10/28/2015 | Jennifer Erfurth | VP | Sell | 6,198 | $66.04 | $409,315.92 | |
| 10/27/2015 | David L. White | CFO | Sell | 8,426 | $66.85 | $563,278.10 | |
| 10/27/2015 | Greg J. Santora | Director | Sell | 20,000 | $66.95 | $1,339,000.00 | |
| 8/25/2015 | Andrea Lynn Saia | Director | Sell | 3,567 | $55.10 | $196,541.70 | |
| 8/20/2015 | Warren S. Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | |
| 8/17/2015 | Thomas M Prescott | Director | Sell | 40,000 | $60.50 | $2,420,000.00 | |
| 5/15/2015 | Jennifer Erfurth | VP | Sell | 2,400 | $59.27 | $142,248.00 | |
| 5/7/2015 | C Raymond Larkin Jr | Director | Sell | 15,000 | $59.03 | $885,450.00 | |
| 5/6/2015 | Warren S Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | |
| 5/5/2015 | David L White | CFO | Sell | 1,899 | $59.37 | $112,743.63 | |
| 5/5/2015 | John Patrick Graham | CMO | Sell | 1,139 | $60.37 | $68,761.43 | |
| 5/5/2015 | Timothy A Mack | VP | Sell | 28,280 | $59.47 | $1,681,811.60 | |
| 5/1/2015 | Roger E George | VP | Sell | 23,248 | $58.69 | $1,364,425.12 | |
| 2/26/2015 | Raphael Pascaud | VP | Sell | 6,500 | $56.40 | $366,600.00 | |
| 2/24/2015 | Christopher C Puco | VP | Sell | 11,982 | $56.40 | $675,784.80 | |
| 11/4/2014 | Timothy A Mack | VP | Sell | 9,375 | $52.17 | $489,093.75 | |
| 10/28/2014 | C Raymond Larkin Jr | Director | Sell | 15,000 | $51.54 | $773,100.00 | |
| 10/28/2014 | Jennifer Erfurth | VP | Sell | 6,242 | $52.25 | $326,144.50 | |
| 8/27/2014 | Roger E George | VP | Sell | 10,875 | $55.85 | $607,368.75 | |
| 8/21/2014 | David L White | CFO | Sell | 4,600 | $54.42 | $250,332.00 | |
| 8/21/2014 | John Patrick Graham | CMO | Sell | 7,046 | $54.41 | $383,372.86 | |
| 8/19/2014 | Thomas M Prescott | CEO | Sell | 14,896 | $55.07 | $820,322.72 | |
| 5/29/2014 | Timothy A Mack | VP | Sell | 16,333 | $55.06 | $899,294.98 | |
| 5/1/2014 | Raphael Pascaud | VP | Sell | 2,000 | $50.79 | $101,580.00 | |
| 2/25/2014 | Christopher Puco | VP | Sell | 4,462 | $54.09 | $241,349.58 | |
| 2/24/2014 | Roger George | VP | Sell | 19,474 | $54.23 | $1,056,075.02 | |
| 2/11/2014 | Jennifer Erfurth | VP | Sell | 3,144 | $55.34 | $173,988.96 | |
| 2/7/2014 | Thomas Prescott | CEO | Sell | 236,979 | $54.64 | $12,948,532.56 | |
| 2/4/2014 | Timothy Mack | VP | Sell | 12,761 | $54.73 | $698,409.53 | |
| 2/4/2014 | Warren Thaler | Director | Sell | 18,000 | $54.75 | $985,500.00 | |
| 10/31/2013 | Jennifer Erfurth | VP | Sell | 3,242 | $56.97 | $184,696.74 | |
| 10/30/2013 | Richard M.L. Twomey | VP | Sell | 4,010 | $57.05 | $228,770.50 | |
| 10/30/2013 | Thomas M Prescott | CEO | Sell | 188,176 | $56.88 | $10,703,450.88 | |
| 10/30/2013 | Warren S Thaler | Director | Sell | 35,250 | $56.55 | $1,993,387.50 | |
| 10/22/2013 | George J Morrow | Director | Sell | 75,000 | $57.27 | $4,295,250.00 | |
| 10/22/2013 | Thomas M Prescott | CEO | Sell | 74,513 | $58.00 | $4,321,754.00 | |
| 8/29/2013 | Richard M.L. Twomey | VP | Sell | 2,135 | $43.76 | $93,427.60 | |
| 8/29/2013 | Timothy Mack | SVP | Sell | 18,477 | $43.32 | $800,423.64 | |
| 8/9/2013 | Joseph Lacob | Director | Sell | 8,000 | $43.85 | $350,800.00 | |
| 8/1/2013 | Greg Santora | Director | Sell | 16,000 | $43.79 | $700,640.00 | |
| 7/30/2013 | Warren S Thaler | Director | Sell | 10,000 | $42.24 | $422,400.00 | |
| 7/25/2013 | Roger E George | VP | Sell | 26,252 | $43.55 | $1,143,274.60 | |
| 7/24/2013 | Richard M.L. Twomey | VP | Sell | 4,532 | $43.42 | $196,779.44 | |
| 5/31/2013 | Joseph Lacob | Director | Sell | 49,998 | $36.16 | $1,807,927.68 | |
| 5/15/2013 | Richard M.L. Twomey | VP | Sell | 1,875 | $36.10 | $67,687.50 | |
| 2/4/2013 | Len Hedge | SVP | Sell | 100,000 | $31.38 | $3,138,000.00 | |
| 11/12/2012 | Dan Scott Ellis | VP | Sell | 18,815 | $26.52 | $498,973.80 | |
| 8/9/2012 | Joseph Lacob | Director | Sell | 300,000 | $34.97 | $10,491,000.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Align Technology (NASDAQ:ALGN)
Latest Headlines for Align Technology (NASDAQ:ALGN)
| Source: |
|
| Date | Headline |
|---|
 | $343.25 Million in Sales Expected for Align Technology, Inc. (ALGN) This Quarter
www.americanbankingnews.com - July 21 at 3:10 PM |
| Align Technology, Inc. (ALGN) to Post FY2017 Earnings of $3.31 Per Share, Northcoast Research Forecasts
www.americanbankingnews.com - July 21 at 11:21 AM |
 | S&P Stealth Outperformers: Health Care - Investopedia
www.investopedia.com - July 20 at 10:07 PM |
 | Align Technology (ALGN) Q2 Earnings: A Beat in the Cards? - Nasdaq
www.nasdaq.com - July 20 at 10:07 PM |
 | Quest Diagnostics Closes Deal to Acquire 2 Labs in Texas
finance.yahoo.com - July 20 at 5:05 PM |
| Align Technology (ALGN) Q2 Earnings: A Beat in the Cards?
finance.yahoo.com - July 20 at 5:05 PM |
| S&P Stealth Outperformers: Health Care
finance.yahoo.com - July 20 at 5:05 PM |
| Align Technology, Inc. (ALGN) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - July 20 at 7:07 AM |
| Zacks: Analysts Anticipate Align Technology, Inc. (ALGN) to Announce $0.73 EPS
www.americanbankingnews.com - July 19 at 4:04 PM |
| Medtronic InterStim System Shows Five-Year Positive Results ... - Nasdaq
www.nasdaq.com - July 18 at 5:11 PM |
| Why Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock? - Nasdaq
www.nasdaq.com - July 17 at 9:09 PM |
| Morgan Stanley Raises Align Technology, Inc. (NASDAQ:ALGN) Price Target to $182.00
www.americanbankingnews.com - July 17 at 7:44 PM |
 | Align Technology (ALGN): Raising Estimates - Morgan Stanley - StreetInsider.com
www.streetinsider.com - July 17 at 4:06 PM |
| Hill-Rom (HRC) at 52-Week High: What's Driving the Stock? - Nasdaq
www.nasdaq.com - July 17 at 4:06 PM |
| Credit Suisse Group Reaffirms Outperform Rating for Align Technology, Inc. (NASDAQ:ALGN)
www.americanbankingnews.com - July 16 at 7:02 PM |
| Proposed Vivos Merger Could Take IMSCQ from Cents to Dollars
finance.yahoo.com - July 16 at 8:12 AM |
| Avantor to Acquire VWR, Consolidation Promises Global Gains - Nasdaq
www.nasdaq.com - July 14 at 10:32 PM |
| Medtronic Enrolls First Patient Under STOP AF First Trial
finance.yahoo.com - July 13 at 4:31 PM |
| Here's Why You Should Add ResMed to Your Portfolio Now - Nasdaq
www.nasdaq.com - July 12 at 4:09 PM |
| Express Scripts Rides High on Increased Generic Utilization - Nasdaq
www.nasdaq.com - July 12 at 4:09 PM |
| Neogen Introduces Test for Listeria in Environmental Samples - Nasdaq
www.nasdaq.com - July 11 at 5:01 PM |
| Myriad Genetics to Grow with Study Successes, New Alliances - Nasdaq
www.nasdaq.com - July 10 at 8:40 PM |
 | Align Technology Unveils New Company Logo to Unify the Invisalign and iTero Brands Under One Corporate Brand ... - Benzinga
www.benzinga.com - July 10 at 8:40 PM |
| Myriad Genetics to Grow with Study Successes, New Alliances
finance.yahoo.com - July 10 at 8:40 PM |
| Align Technology Unveils New Company Logo to Unify the Invisalign and iTero Brands Under One Corporate Brand Identity
finance.yahoo.com - July 10 at 8:40 PM |
| Investors Look for Gains as Abbott Labs Set to Acquire Alere - Nasdaq
www.nasdaq.com - July 10 at 3:38 PM |
| Baxter and TAU Ink New Licensing Agreements through Ramot
finance.yahoo.com - July 7 at 5:59 PM |
| ResMed Sees Potential in SDB Market, Eyes Global Growth
finance.yahoo.com - July 7 at 5:59 PM |
| Will Walgreens Gain from Revised Rite Aid Agreement? - Nasdaq
www.nasdaq.com - July 7 at 3:09 AM |
| Abbott Freestyle Libre System Gets Health Canada License - Nasdaq
www.nasdaq.com - July 5 at 4:25 PM |
| Omnicell (OMCL) Rides on Acquisitions Amid Tough Competition - Nasdaq
www.nasdaq.com - July 5 at 4:25 PM |
| Here's Why You Can Buy Quest Diagnostics Stock Right Now - Nasdaq
www.nasdaq.com - July 4 at 5:49 PM |
| Here's Why You Can Buy Quest Diagnostics Stock Right Now
finance.yahoo.com - July 4 at 5:49 PM |
| 5 Hottest Stocks Of The First Half Of 2017 - Benzinga
www.benzinga.com - July 3 at 3:38 PM |
| Lantheus Holdings at 52-Week High: What's Driving the Stock? - Nasdaq
www.nasdaq.com - July 3 at 3:38 PM |
| Illumina Offers FDA-Approved NGS Cancer Companion Test Kit - Nasdaq
www.nasdaq.com - July 3 at 3:38 PM |
| Envision Healthcare (EVHC) Acquires Anesthesia Associates - Nasdaq
www.nasdaq.com - July 3 at 3:38 PM |
| Align Technology to Announce Second Quarter 2017 Results on July 27, 2017
finance.yahoo.com - July 3 at 3:38 PM |
| Envision Healthcare (EVHC) Acquires Anesthesia Associates
finance.yahoo.com - July 3 at 3:38 PM |
| Lantheus Holdings at 52-Week High: What's Driving the Stock?
finance.yahoo.com - July 3 at 3:38 PM |
| Illumina Offers FDA-Approved NGS Cancer Companion Test Kit
finance.yahoo.com - July 3 at 3:38 PM |
| 5 Hottest Stocks Of The First Half Of 2017
finance.yahoo.com - July 3 at 3:38 PM |
| Align Technology, Inc. (ALGN) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 3 at 9:56 AM |
| Reviewing Align Technology (ALGN) and STAAR Surgical Company (STAA)
www.americanbankingnews.com - July 3 at 12:22 AM |
| Boston Scientific Rides on New Growth Plans amid Headwinds - Nasdaq
www.nasdaq.com - June 30 at 3:47 PM |
| Abaxis (ABAX) Product Portfolio Strong, Competition Rife - Nasdaq
www.nasdaq.com - June 30 at 3:47 PM |
| BioScrip (BIOS) Strong on Infusion, Reimbursement a Drag - Nasdaq
www.nasdaq.com - June 30 at 3:47 PM |
| Boston Scientific Rides on New Growth Plans amid Headwinds
finance.yahoo.com - June 30 at 3:47 PM |
| Medtronic (MDT) Partners with Aetna for Type 1 & 2 Diabetes (Revised) - Nasdaq
www.nasdaq.com - June 29 at 9:42 PM |
| Walgreens (WBA) Tops Q3 Earnings, Scraps Rite-Aid Deal - Nasdaq
www.nasdaq.com - June 29 at 4:42 PM |
Align Technology (ALGN) Chart for Tuesday, July, 25, 2017
